Delivery Order SPE2DB20D3103-SPE2DB23FN0Z4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $148,758.81 delivery order contract is for the supply of Rosuvastatin Calcium 40 mg tablets to support military healthcare programs. The contract has a performance period through January 31, 2024 and uses a firm fixed price pricing type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $34,256.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Rosuvastatin Calcium 40 mg tablets in 500-count bottles. This is a firm-fixed-price delivery order with a completion date of September 26, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award, valued at $7,231.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 500 tablets of Rosuvastatin Calcium 5 mg, a cardiovascular medication, to support military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,268.53 firm fixed-price delivery order is for the supply of 500 units of Rosuvastatin Calcium 5 mg tablets. The contract has an ultimate completion date of December 19, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 500 units of Rosuvastatin Calcium 40 mg tablets. The $15,497.62 firm fixed-price delivery order contract has a completion date of May 22, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $17,020.10 delivery order is for Rosuvastatin Calcium 5 mg tablets, a cardiovascular medication. This award falls under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4,563,448,409 Rosuvastatin Calcium 10 mg tablets in 1,000-count bottles. The $4,138.94 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,154.47 Firm Fixed Price delivery order is for the supply of Rosuvastatin Calcium 10 mg tablets to DLA facilities. The award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,164.29, is for the delivery of Rosuvastatin Calcium 40 mg tablets. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award, valued at $5,880.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rosuvastatin Calcium 5 mg tablets, a medication used to treat high cholesterol. The contract has a firm fixed price and a completion date of November 15, 2024. Additionally, AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN0Z4Delivery Order
This federal contract award, valued at $17,373.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Rosuvastatin Calcium 5 mg tablets in quantities of 500 tablets, with a completion date of April 18, 2023. This is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.4k | 4/17/23 |